Avaleht › 1. tüüpi diabeet › Pennsylvania
1. tüüpi diabeet kliinilised uuringud osariigis Pennsylvania
13 uuringut haiguse 1. tüüpi diabeet jaoks otsivad osalejaid osariigis Pennsylvania.
Linnad osariigis Pennsylvania
Ametlik uuringutekst (inglise keeles)
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Children's Hospital of Philadelphia (CHOP), Philadelphia
VärbamineFaas 3
Vanused 1–35 · Kõik sood · Uuendatud 22. sept 2026 · NCT07222137A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
VärbamineFaas 3
Vanused 1–35 · Kõik sood · Uuendatud 22. sept 2026 · NCT07222332A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- The Children's Hospital of Philadelphia- Site Number : 8400039, Philadelphia
VärbamineFaas 3
Vanused 1–25 · Kõik sood · Uuendatud 14. sept 2026 · NCT07088068Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- University of Pittsburgh, Pittsburgh
VärbamineFaas 2
Vanused 4–34 · Kõik sood · Uuendatud 9. sept 2026 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- University of Pittsburgh, Pittsburgh
VärbamineFaas 2
Vanused 8–45 · Kõik sood · Uuendatud 8. sept 2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- University of Pittsburgh, Pittsburgh
VärbamineFaas 1/2
Vanused 9–20 · Kõik sood · Uuendatud 2. sept 2026 · NCT07061574A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Hospital of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center Montefiore, Pittsburgh
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 1. sept 2026 · NCT04786262SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- The Children's Hospital of Philadelphia, Philadelphia
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
VärbamineFaas 2
Vanused 5–40 · Kõik sood · Uuendatud 24. aug 2026 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Pennsylvania, Philadelphia
Värbamine
Vanused 18–65 · Kõik sood · Uuendatud 16. juuli 2026 · NCT06880835Registry for Stage 2 Type 1 Diabetes
- Hospital of The University of Pennsylvania- Site Number : 8400021, Philadelphia
- The Children's Hospital of Philadelphia- Site Number : 8400029, Philadelphia
VärbamineVaatlusuuring
Kõik vanused · Kõik sood · Uuendatud 13. apr 2026 · NCT06481904An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
- Perelman Center for Advanced Medicine - Endocrinology, Philadelphia
- Montefiore Clinical and Translational Research Center - Endocrinology, Pittsburgh
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 23. märts 2026 · NCT06832410Closed Loop and Education for Hypoglycemia Awareness Restoration
- University of Pennsylvania, Philadelphia
Värbamine
Vanused 18–75 · Kõik sood · Uuendatud 3. märts 2026 · NCT06325202TrialNet Pathway to Prevention of T1D
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 2–45 · Kõik sood · Uuendatud 1. juuli 2025 · NCT00097292Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.